Only 5% of U.S. blood donors are African American, but sickle cell patients need phenotypically matched blood that overwhelmingly comes from Black donors

More than 100,000 people in the United States have sickle cell disease (SCD), and the vast majority are of African or Mediterranean descent. Many require chronic transfusion therapy — regular blood transfusions every 3-4 weeks to prevent strokes, organ damage, and pain crises. But sickle cell patients who receive frequent transfusions develop alloantibodies against foreign blood cell antigens at alarming rates (estimated 4-7% develop overt delayed hemolytic transfusion reactions), making each successive transfusion harder to match safely. The best way to prevent alloimmunization is to match donors and recipients on extended red cell antigens (beyond just ABO and Rh) — and those antigen profiles are far more common in donors of African descent. Here is the core mismatch: African Americans represent only 5% of blood donors in the U.S., while approximately 74% of donors are white. The discrepancy is even starker among repeat donors — about 83% of repeat donors are white. One in three African American blood donors is a match for a sickle cell patient, but the pool is so small that blood centers routinely cannot find enough compatible units. When they cannot find a match, they must either delay the transfusion (risking stroke or organ damage), use less-well-matched blood (risking a hemolytic reaction), or give smaller "split" transfusions that provide suboptimal therapy. This persists because of deep structural barriers to blood donation in Black communities. Historical medical exploitation (Tuskegee, Henrietta Lacks) has created justified distrust of medical institutions. Blood drives are disproportionately held at workplaces and colleges with less racial diversity. Many blood centers have not invested adequately in culturally competent outreach or placed donation centers in predominantly Black neighborhoods. The Red Cross's PreciseMatch program and NYBC's similar initiative have tried to recruit donors of African descent specifically for sickle cell matching, but these programs remain small relative to the need. The result is that the patients who need the most carefully matched blood are the ones least likely to get it.